Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
786.78
267.09
307.27
342.41
655.08
240.03
280.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
786.78
267.09
307.27
342.41
655.08
240.03
280.66
Raw Material Cost
309.45
111.89
130.10
142.95
277.10
104.45
121.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.02
0.02
0.02
0.03
0.03
Selling and Distribution Expenses
265.18
93.28
123.42
103.37
203.22
82.32
105.10
Other Expenses
0.80
0.80
1.20
0.83
0.83
0.73
1.00
Total Expenditure (Excl Depreciation)
582.62
213.14
265.56
254.64
488.63
194.07
236.95
Operating Profit (PBDIT) excl Other Income
204.20000000000002
54
41.7
87.8
166.4
46
43.7
Other Income
3.64
5.62
10.74
9.31
13.22
4.42
4.05
Operating Profit (PBDIT)
204.56
60.85
53.65
99.20
179.46
51.37
50.30
Interest
0.01
0.01
0.02
0.02
0.02
0.03
0.03
Exceptional Items
3.83
2.36
0.43
-0.39
-3.97
4.77
3.59
Gross Profit (PBDT)
477.32
155.20
177.17
199.47
377.97
135.58
158.88
Depreciation
5.99
5.99
5.38
5.38
5.71
5.71
5.40
Profit Before Tax
202.39
57.21
48.69
93.42
169.75
50.40
48.47
Tax
29.94
4.57
0.23
14.89
26.42
6.20
9.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
172.46
52.64
48.45
78.52
143.33
44.20
39.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
172.46
52.64
48.45
78.52
143.33
44.20
39.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
172.46
52.64
48.45
78.52
143.33
44.20
39.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,340.88
2,273.62
2,220.98
2,172.53
2,174.92
2,124.65
2,080.45
Earnings per share (EPS)
0.43
0.13
0.12
0.19
0.35
0.11
0.1
Diluted Earnings per share
0.43
0.13
0.12
0.19
0.35
0.11
0.1
Operating Profit Margin (Excl OI)
24.78%
18.44%
12.21%
24.68%
24.5%
17.18%
14.56%
Gross Profit Margin
26.49%
23.66%
17.6%
28.85%
26.78%
23.38%
19.19%
PAT Margin
21.92%
19.71%
15.77%
22.93%
21.88%
18.41%
13.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 20.10% vs 13.48% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 20.38% vs -0.90% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 20.88% vs 3.04% in Jun 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Runben Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
786.78
0
786.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
786.78
0
786.78
Raw Material Cost
309.45
0
309.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
265.18
0
265.18
Other Expenses
0.80
0.00
0.80
Total Expenditure (Excl Depreciation)
582.62
0
582.62
Operating Profit (PBDIT) excl Other Income
204.16
0.00
204.16
Other Income
3.64
0
3.64
Operating Profit (PBDIT)
204.56
0
204.56
Interest
0.01
0
0.01
Exceptional Items
3.83
0
3.83
Gross Profit (PBDT)
477.32
0
477.32
Depreciation
5.99
0
5.99
Profit Before Tax
202.39
0
202.39
Tax
29.94
0
29.94
Provisions and contingencies
0
0
0.00
Profit After Tax
172.46
0
172.46
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
172.46
0
172.46
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
172.46
0
172.46
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,340.88
0
2,340.88
Earnings per share (EPS)
0.43
0
0.43
Diluted Earnings per share
0.43
0
0.43
Operating Profit Margin (Excl OI)
24.78%
0%
0.00
24.78%
Gross Profit Margin
26.49%
0%
0.00
26.49%
PAT Margin
21.92%
0%
0.00
21.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 78.68 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 194.57% vs -13.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.10% vs 13.48% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 17.25 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 227.95% vs 8.45% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.38% vs -0.90% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.09 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 263.95% vs 28.67% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.88% vs 3.04% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.78%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
